MRSH

• None no insider bought on the open market
• $5.3M sold by 4 insiders outside a trading plan
• $12.9M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Katherine Brennan SVP and General Counsel
   Sale
   $225K 1,197 shares at $187.90 14% of stake
   Traded Sep 2 Filed Sep 3
   ↗
3. John Q Doyle CEO
   Planned sale
   $3.1M 16,656 shares at $188.51 13% of stake
   Traded Sep 2 Filed Sep 3
   ↗
4. John Jude Jones Chief Marketing Officer
   Sale
   $1.2M 6,500 shares at $191.96 82% of stake
   Traded Aug 6 Filed Aug 7
   ↗
5. Paul Beswick SVP, Chief Information Officer
   Planned sale
   $141K 713 shares at $198.00 4.2% of stake
   Traded Jul 29 Filed Jul 31
   ↗
6. Martin South Chief Client Officer
   Sale
   $1.3M 7,100 shares at $189.99 30% of stake
   Traded Jul 28 Filed Jul 29
   ↗
7. Lloyd M Yates Director
   Sale
   $2.1M 12,000 shares at $175.65 50% of stake
   Traded Jul 23 Filed Jul 24
   ↗
8. John Q Doyle CEO
   Planned sale
   $2.7M 16,656 shares at $161.71 13% of stake
   Traded Jun 2 Filed Jun 3
   ↗
9. John Jude Jones Chief Marketing Officer
   Sale
   $410K 2,362 shares at $173.61 23% of stake
   Traded Mar 11 Filed Mar 12
   ↗
10. John Q Doyle CEO
    Planned sale
    $3.1M 16,655 shares at $183.30 13% of stake
    Traded Mar 4 Filed Mar 5
    ↗
11. John Q Doyle CEO
    Planned sale
    $3.8M 21,079 shares at $182.22 19% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 12 share withholdings for taxes, 10 stock grants, and 1 sale to cover taxes.